Plasmodium immunomics

International Journal for Parasitology

Volumn 41, Issue 1, 2011, Pages 3-20

  Doolan, Denise L ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Antigen discovery; Antigen identification; Diagnostics; Immune screening; Immunomics; Malaria; Plasmodium; Vaccine

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; CHLOROQUINE; EPITOPE; EXPORTED PROTEIN 1; LIVE VACCINE; LIVER STAGE ANTIGEN 1; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 2; PARASITE ANTIGEN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; UNCLASSIFIED DRUG;

ANTIBODY; ANTIGEN; IMMUNE RESPONSE; IMMUNOASSAY; MALARIA; PARASITE; VACCINE;

ANTIGEN EXPRESSION; ANTIMALARIAL ACTIVITY; CELLULAR IMMUNITY; DRUG TARGETING; GENETIC DATABASE; GENETIC TRANSCRIPTION; GENOMICS; HIGH THROUGHPUT SCREENING; HLA SYSTEM; HOST PARASITE INTERACTION; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENETICS; IMMUNOGENICITY; IMMUNOMICS; MALARIA; NONHUMAN; PLASMODIUM; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEIN TARGETING; PROTEOMICS; REVIEW; SEROLOGY; SPOROZOITE;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BIOMEDICAL RESEARCH; EPITOPES; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; MALARIA VACCINES; PLASMODIUM; PRIMATES; PROTEOME; RODENTIA; T-LYMPHOCYTES;

PLASMODIUM PARASITES; PRIMATES; RODENTIA;

EID: 78650219138     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2010.08.002     Document Type: Review

References (174)

1. Aguiar J.C., LaBaer J., Blair P.L., Shamailova V.Y., Koundinya M., Russell J.A., Huang F., Mar W., Anthony R.M., Witney A., Caruana S.R., Brizuela L., Sacci J.B., Hoffman S.L., Carucci D.J. High-throughput generation of P. falciparum functional molecules by recombinational cloning. Genome Res. 2004, 14:2076-2082.
2. Baird J.K. Age-dependent characteristics of protection versus susceptibility to Plasmodium falciparum. Ann. Trop. Med. Parasitol. 1998, 92:367-390.
3. Barbour A.G., Jasinskas A., Kayala M.A., Davies D.H., Steere A.C., Baldi P., Felgner P.L. A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi. Infect. Immun. 2008, 76:3374-3389.
4. Barry A.E., Schultz L., Buckee C.O., Reeder J.C. Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum. PLoS ONE 2009, 4:e8497.
5. Beare P.A., Chen C., Bouman T., Pablo J., Unal B., Cockrell D.C., Brown W.C., Barbian K.D., Porcella S.F., Samuel J.E., Felgner P.L., Heinzen R.A. Candidate antigens for Q fever serodiagnosis revealed by immunoscreening of a Coxiella burnetii protein microarray. Clin. Vaccine Immunol. 2008, 15:1771-1779.
6. Beaudoin R.L., Strome C.P.A., Mitchell F., Tubergen T.A. Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen. Exp. Parasitol. 1977, 42:1-5.
7. Bejon P., Mwacharo J., Kai O., Mwangi T., Milligan P., Todryk S., Keating S., Lang T., Lowe B., Gikonyo C., Molyneux C., Fegan G., Gilbert S.C., Peshu N., Marsh K., Hill A.V. A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya. PLoS Clin. Trials 2006, 1:e29.
8. Belnoue E., Costa F.T., Frankenberg T., Vigario A.M., Voza T., Leroy N., Rodrigues M.M., Landau I., Snounou G., Renia L. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J. Immunol. 2004, 172:2487-2495.
9. Benhnia M.R., McCausland M.M., Su H.P., Singh K., Hoffmann J., Davies D.H., Felgner P.L., Head S., Sette A., Garboczi D.N., Crotty S. Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine. J. Virol. 2008, 82:3751-3768.
10. Birkholtz L.M., Blatch G., Coetzer T.L., Hoppe H.C., Human E., Morris E.J., Ngcete Z., Oldfield L., Roth R., Shonhai A., Stephens L., Louw A.I. Heterologous expression of plasmodial proteins for structural studies and functional annotation. Malar. J. 2008, 7:197.
11. Blair P.L., Carucci D.J. Functional proteome and expression analysis of sporozoites and hepatic stages of malaria development. Curr. Top. Microbiol. Immunol. 2005, 295:417-438.
12. Bozdech Z., Llinas M., Pulliam B.L., Wong E.D., Zhu J., DeRisi J.L. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol. 2003, 1:E5.
13. Bozdech Z., Mok S., Hu G., Imwong M., Jaidee A., Russell B., Ginsburg H., Nosten F., Day N.P., White N.J., Carlton J.M., Preiser P.R. The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc. Natl. Acad. Sci. USA 2008, 105:16290-16295.
14. Bruder J.T., Angov E., Limbach K.J., Richie T.L. Molecular vaccines for malaria. Hum. Vaccine 2010, 6:54-77.
15. Carlton J.M., Angiuoli S.V., Suh B.B., Kooij T.W., Pertea M., Silva J.C., Ermolaeva M.D., Allen J.E., Selengut J.D., Koo H.L., Peterson J.D., Pop M., Kosack D.S., Shumway M.F., Bidwell S.L., Shallom S.J., van Aken S.E., Riedmuller S.B., Feldblyum T.V., Cho J.K., Quackenbush J., Sedegah M., Shoaibi A., Cummings L.M., Florens L., Yates J.R., Raine J.D., Sinden R.E., Harris M.A., Cunningham D.A., Preiser P.R., Bergman L.W., Vaidya A.B., van Lin L.H., Janse C.J., Waters A.P., Smith H.O., White O.R., Salzberg S.L., Venter J.C., Fraser C.M., Hoffman S.L., Gardner M.J., Carucci D.J. Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature 2002, 419:512-519.
16. Carlton J., Silva J., Hall N. The genome of model malaria parasites, and comparative genomics. Curr. Issues Mol. Biol. 2005, 7:23-37.
17. Carlton J.M., Adams J.H., Silva J.C., Bidwell S.L., Lorenzi H., Caler E., Crabtree J., Angiuoli S.V., Merino E.F., Amedeo P., Cheng Q., Coulson R.M., Crabb B.S., Del Portillo H.A., Essien K., Feldblyum T.V., Fernandez-Becerra C., Gilson P.R., Gueye A.H., Guo X., Kang'a S., Kooij T.W., Korsinczky M., Meyer E.V., Nene V., Paulsen I., White O., Ralph S.A., Ren Q., Sargeant T.J., Salzberg S.L., Stoeckert C.J., Sullivan S.A., Yamamoto M.M., Hoffman S.L., Wortman J.R., Gardner M.J., Galinski M.R., Barnwell J.W., Fraser-Liggett C.M. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 2008, 455:757-763.
18. + T-cell responses against malaria liver stages. Nat. Med. 2002, 8:166-170.
19. Chen C., Bouman T.J., Beare P.A., Mertens K., Zhang G.Q., Russell-Lodrigue K.E., Hogaboam J.P., Peters B., Felgner P.L., Brown W.C., Heinzen R.A., Hendrix L.R., Samuel J.E. A systematic approach to evaluate humoral and cellular immune responses to Coxiella burnetii immunoreactive antigens. Clin. Microbiol. Infect. 2009, 15(Suppl. 2):156-157.
20. Cohen J., Nussenzweig V., Nussenzweig R., Vekemans J., Leach A. From the circumsporozoite protein to the RTS, S/AS candidate vaccine. Hum. Vaccine 2010, 6:90-96.
21. Cohen S., McGregor I.A., Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature 1961, 192:733-737.
22. Coppel R.L. Vaccinating with the genome: a Sisyphean task?. Trends Parasitol. 2009, 25:205-212.
23. Corradin G., Kajava A.V. Malaria vaccine: why is it taking so long?. Expert Rev. Vaccines 2010, 9:111-114.
24. Crompton P.D., Kayala M.A., Traore B., Kayentao K., Ongoiba A., Weiss G.E., Molina D.M., Burk C.R., Waisberg M., Jasinskas A., Tan X., Doumbo S., Doumtabe D., Kone Y., Narum D.L., Liang X., Doumbo O.K., Miller L.H., Doolan D.L., Baldi P., Felgner P.L., Pierce S.K. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc. Natl. Acad. Sci. USA 2010, 107:6958-6963.
25. Davies D.H., Liang X., Hernandez J.E., Randall A., Hirst S., Mu Y., Romero K.M., Nguyen T.T., Kalantari-Dehaghi M., Crotty S., Baldi P., Villarreal L.P., Felgner P.L. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc. Natl. Acad. Sci. USA 2005, 102:547-552.
26. Davies D.H., McCausland M.M., Valdez C., Huynh D., Hernandez J.E., Mu Y., Hirst S., Villarreal L., Felgner P.L., Crotty S. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J. Virol. 2005, 79:11724-11733.
27. Davies D.H., Molina D.M., Wrammert J., Miller J., Hirst S., Mu Y., Pablo J., Unal B., Nakajima-Sasaki R., Liang X., Crotty S., Karem K.L., Damon I.K., Ahmed R., Villarreal L., Felgner P.L. Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics 2007, 7:1678-1686.
28. Davies D.H., Wyatt L.S., Newman F.K., Earl P.L., Chun S., Hernandez J.E., Molina D.M., Hirst S., Moss B., Frey S.E., Felgner P.L. Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax. J. Virol. 2008, 82:652-663.
29. De Groot A.S., Berzofsky J.A. From genome to vaccine - new immunoinformatics tools for vaccine design. Methods 2005, 34:425-428.
30. de Koning-Ward T.F., Gilson P.R., Boddey J.A., Rug M., Smith B.J., Papenfuss A.T., Sanders P.R., Lundie R.J., Maier A.G., Cowman A.F., Crabb B.S. A newly discovered protein export machine in malaria parasites. Nature 2009, 459:945-949.
31. Depla E., Van der Aa A., Livingston B.D., Crimi C., Allosery K., De Brabandere V., Krakover J., Murthy S., Huang M., Power S., Babe L., Dahlberg C., McKinney D., Sette A., Southwood S., Philip R., Newman M.J., Meheus L. Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections. J. Virol. 2008, 82:435-450.
32. + T cell mediated protective immunity against malaria. Mol. Immunol. 2007, 44:2235-2248.
33. Doherty P.C., Zinkernagel R.M. Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex. Nature 1975, 256:50-52.
34. Doherty P.C., Zinkernagel R.M. A biological role for the major histocompatibility antigens. Lancet 1975, 1:1406-1409.
35. Doolan D.L., Saul A.J., Good M.F. Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development. Infect. Immun. 1992, 60:675-682.
36. + cell-, interferon gamma-, and nitric oxide-dependent immunity. J. Exp. Med. 1996, 183:1739-1746.
37. + T-cell epitopes of multiple Plasmodium falciparum antigens. Vaccines 97: Molecular Approaches to the Control of Infectious Diseases 1997, 207-211. Cold Spring Harbor Laboratory Press, New York. F. Brown, D. Burton, P. Doherty, J. Mekalanos, E. Norrby (Eds.).
38. Doolan D.L., Hoffman S.L., Southwood S., Wentworth P.A., Sidney J., Chesnut R.W., Keogh E., Appella E., Nutman T.B., Lal A.A., Gordon D.M., Oloo A., Sette A. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 1997, 7:97-112.
39. Doolan D.L., Southwood S., Chesnut R., Appella E., Gomez E., Richards A., Higashimoto Y.I., Maewal A., Sidney J., Gramzinski R.A., Mason C., Koech D., Hoffman S.L., Sette A. HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre- erythrocytic-stage antigens restricted by multiple HLA class II alleles. J. Immunol. 2000, 165:1123-1137.
40. Doolan D.L., Southwood S., Freilich D.A., Sidney J., Graber N.L., Shatney L., Bebris L., Florens L., Dobano C., Witney A.A., Appella E., Hoffman S.L., Yates J.R., Carucci D.J., Sette A. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc. Natl. Acad. Sci. USA 2003, 100:9952-9957.
41. Doolan D.L., Martinez-Alier N. Immune response to pre-erythrocytic stages of malaria parasites. Curr. Mol. Med. 2006, 6:169-185.
42. Doolan D.L., Mu Y., Unal B., Sundaresh S., Hirst S., Valdez C., Randall A., Molina D., Liang X., Freilich D.A., Oloo J.A., Blair P.L., Aguiar J.C., Baldi P., Davies D.H., Felgner P.L. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 2008, 8:4680-4694.
43. Doolan D.L., Dobano C., Baird J.K. Acquired immunity to malaria. Clin. Microbiol. Rev. 2009, 22:13-36. (Table of Contents).
44. Driguez P., Doolan D.L., Loukas A., Felgner P.L., McManus D.P. Schistosomiasis vaccine discovery using immunomics. Parasit. Vectors 2010, 3:4.
45. Duan J., Mu J., Thera M.A., Joy D., Kosakovsky Pond S.L., Diemert D., Long C., Zhou H., Miura K., Ouattara A., Dolo A., Doumbo O., Su X.Z., Miller L. Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine design. Proc. Natl. Acad. Sci. USA 2008, 105:7857-7862.
46. Epstein J.E., Giersing B., Mullen G., Moorthy V., Richie T.L. Malaria vaccines: are we getting closer?. Curr. Opin. Mol. Ther. 2007, 9:12-24.
47. Eyles J.E., Unal B., Hartley M.G., Newstead S.L., Flick-Smith H., Prior J.L., Oyston P.C., Randall A., Mu Y., Hirst S., Molina D.M., Davies D.H., Milne T., Griffin K.F., Baldi P., Titball R.W., Felgner P.L. Immunodominant Francisella tularensis antigens identified using proteome microarray. Dstl. Proteomics 2007, 7:2172-2183.
48. Felgner P.L., Kayala M.A., Vigil A., Burk C., Nakajima-Sasaki R., Pablo J., Molina D.M., Hirst S., Chew J.S., Wang D., Tan G., Duffield M., Yang R., Neel J., Chantratita N., Bancroft G., Lertmemongkolchai G., Davies D.H., Baldi P., Peacock S., Titball R.W. A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc. Natl. Acad. Sci. USA 2009, 106:13499-13504.
49. Fleischmann R.D., Adams M.D., White O., Clayton R.A., Kirkness E.F., Kerlavage A.R., Bult C.J., Tomb J.F., Dougherty B.A., Merrick J.M., et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 1995, 269:496-512.
50. Florens L., Washburn M.P., Raine J.D., Anthony R.M., Grainger M., Haynes J.D., Moch J.K., Muster N., Sacci J.B., Tabb D.L., Witney A.A., Wolters D., Wu Y., Gardner M.J., Holder A.A., Sinden R.E., Yates J.R., Carucci D.J. A proteomic view of the Plasmodium falciparum life cycle. Nature 2002, 419:520-526.
51. Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W., Carlton J.M., Pain A., Nelson K.E., Bowman S., Paulsen I.T., James K., Eisen J.A., Rutherford K., Salzberg S.L., Craig A., Kyes S., Chan M.S., Nene V., Shallom S.J., Suh B., Peterson J., Angiuoli S., Pertea M., Allen J., Selengut J., Haft D., Mather M.W., Vaidya A.B., Martin D.M., Fairlamb A.H., Fraunholz M.J., Roos D.S., Ralph S.A., McFadden G.I., Cummings L.M., Subramanian G.M., Mungall C., Venter J.C., Carucci D.J., Hoffman S.L., Newbold C., Davis R.W., Fraser C.M., Barrell B. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002, 419:498-511.
52. Gat O., Grosfeld H., Ariel N., Inbar I., Zaide G., Broder Y., Zvi A., Chitlaru T., Altboum Z., Stein D., Cohen S., Shafferman A. Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen. Infect. Immun. 2006, 74:3987-4001.
53. Good M.F., Xu H., Wykes M., Engwerda C.R. Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu. Rev. Immunol. 2005, 23:69-99.
54. Gray J.C., Corran P.H., Mangia E., Gaunt M.W., Li Q., Tetteh K.K., Polley S.D., Conway D.J., Holder A.A., Bacarese-Hamilton T., Riley E.M., Crisanti A. Profiling the antibody immune response against blood stage malaria vaccine candidates. Clin. Chem. 2007, 53:1244-1253.
55. Groathouse N.A., Amin A., Marques M.A., Spencer J.S., Gelber R., Knudson D.L., Belisle J.T., Brennan P.J., Slayden R.A. Use of protein microarrays to define the humoral immune response in leprosy patients and identification of disease-state-specific antigenic profiles. Infect. Immun. 2006, 74:6458-6466.
56. Gruner A.C., Hez-Deroubaix S., Snounou G., Hall N., Bouchier C., Letourneur F., Landau I., Druilhe P. Insights into the P.y. yoelii hepatic stage transcriptome reveal complex transcriptional patterns. Mol. Biochem. Parasitol. 2005, 142:184-192.
57. Gruner A.C., Mauduit M., Tewari R., Romero J.F., Depinay N., Kayibanda M., Lallemand E., Chavatte J.M., Crisanti A., Sinnis P., Mazier D., Corradin G., Snounou G., Renia L. Sterile protection against malaria is independent of immune responses to the circumsporozoite protein. PLoS ONE 2007, 2:e1371.
58. Gygi S.P., Rochon Y., Franza B.R., Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol. Cell Biol. 1999, 19:1720-1730.
59. Hall N., Karras M., Raine J.D., Carlton J.M., Kooij T.W., Berriman M., Florens L., Janssen C.S., Pain A., Christophides G.K., James K., Rutherford K., Harris B., Harris D., Churcher C., Quail M.A., Ormond D., Doggett J., Trueman H.E., Mendoza J., Bidwell S.L., Rajandream M.A., Carucci D.J., Yates J.R., Kafatos F.C., Janse C.J., Barrell B., Turner C.M., Waters A.P., Sinden R.E. A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science 2005, 307:82-86.
60. Hiller N.L., Bhattacharjee S., van Ooij C., Liolios K., Harrison T., Lopez-Estrano C., Haldar K. A host-targeting signal in virulence proteins reveals a secretome in malarial infection. Science 2004, 306:1934-1937.
61. Hoffman S.L., Oster C.N., Plowe C.V., Woollett G.R., Beier J.C., Chulay J.D., Wirtz R.A., Hollingdale M.R., Mugambi M. Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. Science 1987, 237:639-642.
62. Hoffman S.L., Goh L.M., Luke T.C., Schneider I., Le T.P., Doolan D.L., Sacci J., de la Vega P., Dowler M., Paul C., Gordon D.M., Stoute J.A., Church L.W., Sedegah M., Heppner D.G., Ballou W.R., Richie T.L. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 2002, 185:1155-1164.
63. Holt R.A., Subramanian G.M., Halpern A., Sutton G.G., Charlab R., Nusskern D.R., Wincker P., Clark A.G., Ribeiro J.M., Wides R., Salzberg S.L., Loftus B., Yandell M., Majoros W.H., Rusch D.B., Lai Z., Kraft C.L., Abril J.F., Anthouard V., Arensburger P., Atkinson P.W., Baden H., de Berardinis V., Baldwin D., Benes V., Biedler J., Blass C., Bolanos R., Boscus D., Barnstead M., Cai S., Center A., Chaturverdi K., Christophides G.K., Chrystal M.A., Clamp M., Cravchik A., Curwen V., Dana A., Delcher A., Dew I., Evans C.A., Flanigan M., Grundschober-Freimoser A., Friedli L., Gu Z., Guan P., Guigo R., Hillenmeyer M.E., Hladun S.L., Hogan J.R., Hong Y.S., Hoover J., Jaillon O., Ke Z., Kodira C., Kokoza E., Koutsos A., Letunic I., Levitsky A., Liang Y., Lin J.J., Lobo N.F., Lopez J.R., Malek J.A., McIntosh T.C., Meister S., Miller J., Mobarry C., Mongin E., Murphy S.D., O'Brochta D.A., Pfannkoch C., Qi R., Regier M.A., Remington K., Shao H., Sharakhova M.V., Sitter C.D., Shetty J., Smith T.J., Strong R., Sun J., Thomasova D., Ton L.Q., Topalis P., Tu Z., Unger M.F., Walenz B., Wang A., Wang J., Wang M., Wang X., Woodford K.J., Wortman J.R., Wu M., Yao A., Zdobnov E.M., Zhang H., Zhao Q., Zhao S., Zhu S.C., Zhimulev I., Coluzzi M., della Torre A., Roth C.W., Louis C., Kalush F., Mural R.J., Myers E.W., Adams M.D., Smith H.O., Broder S., Gardner M.J., Fraser C.M., Birney E., Bork P., Brey P.T., Venter J.C., Weissenbach J., Kafatos F.C., Collins F.H., Hoffman S.L. The genome sequence of the malaria mosquito Anopheles gambiae. Science 2002, 298:129-149.
64. Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., Venter J.C. Whole-genome shotgun assembly and comparison of human genome assemblies. Proc. Natl. Acad. Sci. USA 2004, 101:1916-1921.
65. Jing L., Chong T.M., Byrd B., McClurkan C.L., Huang J., Story B.T., Dunkley K.M., Aldaz-Carroll L., Eisenberg R.J., Cohen G.H., Kwok W.W., Sette A., Koelle D.M. Dominance and diversity in the primary human CD4 T cell response to replication-competent vaccinia virus. J. Immunol. 2007, 178:6374-6386.
66. Jing L., Davies D.H., Chong T.M., Chun S., McClurkan C.L., Huang J., Story B.T., Molina D.M., Hirst S., Felgner P.L., Koelle D.M. An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling. J. Virol. 2008, 82:7120-7134.
67. Jing L., McCaughey S.M., Davies D.H., Chong T.M., Felgner P.L., De Rosa S.C., Wilson C.B., Koelle D.M. ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans. J. Immunol. Meth. 2009, 347:36-45.
68. John C.C., Moormann A.M., Pregibon D.C., Sumba P.O., McHugh M.M., Narum D.L., Lanar D.E., Schluchter M.D., Kazura J.W. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection. Am. J. Trop. Med. Hyg. 2005, 73:222-228.
69. Kaiser K., Camargo N., Kappe S.H. Transformation of sporozoites into early exoerythrocytic malaria parasites does not require host cells. J. Exp. Med. 2003, 197:1045-1050.
70. Kaiser K., Matuschewski K., Camargo N., Ross J., Kappe S.H. Differential transcriptome profiling identifies Plasmodium genes encoding pre-erythrocytic stage-specific proteins. Mol. Microbiol. 2004, 51:1221-1232.
71. Kappe S.H., Gardner M.J., Brown S.M., Ross J., Matuschewski K., Ribeiro J.M., Adams J.H., Quackenbush J., Cho J., Carucci D.J., Hoffman S.L., Nussenzweig V. Exploring the transcriptome of the malaria sporozoite stage. Proc. Natl. Acad. Sci. USA 2001, 98:9895-9900.
72. Kariu T., Ishino T., Yano K., Chinzei Y., Yuda M. CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts. Mol Microbiol 2006, 59:1369-1379.
73. Klammt C., Lohr F., Schafer B., Haase W., Dotsch V., Ruterjans H., Glaubitz C., Bernhard F. High level cell-free expression and specific labeling of integral membrane proteins. Eur. J. Biochem. 2004, 271:568-580.
74. Kooij T.W., Carlton J.M., Bidwell S.L., Hall N., Ramesar J., Janse C.J., Waters A.P. A Plasmodium whole-genome synteny map: indels and synteny breakpoints as foci for species-specific genes. PLoS Pathog. 2005, 1:e44.
75. Kooij T.W., Matuschewski K. Triggers and tricks of Plasmodium sexual development. Curr. Opin. Microbiol. 2007, 10:547-553.
76. Kumar K.A., Sano G., Boscardin S., Nussenzweig R.S., Nussenzweig M.C., Zavala F., Nussenzweig V. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 2006, 444:937-940.
77. Kumar K.A., Garcia C.R., Chandran V.R., Van Rooijen N., Zhou Y., Winzeler E., Nussenzweig V. Exposure of Plasmodium sporozoites to the intracellular concentration of potassium enhances infectivity and reduces cell passage activity. Mol. Biochem. Parasitol. 2007, 156:32-40.
78. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K., Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P., McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J., Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C., Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J., Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C., Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I., Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S., Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S., Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S., Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A., Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R., Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A., Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W., Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T., Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E., Frazier M., Gibbs R.A., Muzny D.M., Scherer S.E., Bouck J.B., Sodergren E.J., Worley K.C., Rives C.M., Gorrell J.H., Metzker M.L., Naylor S.L., Kucherlapati R.S., Nelson D.L., Weinstock G.M., Sakaki Y., Fujiyama A., Hattori M., Yada T., Toyoda A., Itoh T., Kawagoe C., Watanabe H., Totoki Y., Taylor T., Weissenbach J., Heilig R., Saurin W., Artiguenave F., Brottier P., Bruls T., Pelletier E., Robert C., Wincker P., Smith D.R., Doucette-Stamm L., Rubenfield M., Weinstock K., Lee H.M., Dubois J., Rosenthal A., Platzer M., Nyakatura G., Taudien S., Rump A., Yang H., Yu J., Wang J., Huang G., Gu J., Hood L., Rowen L., Madan A., Qin S., Davis R.W., Federspiel N.A., Abola A.P., Proctor M.J., Myers R.M., Schmutz J., Dickson M., Grimwood J., Cox D.R., Olson M.V., Kaul R., Shimizu N., Kawasaki K., Minoshima S., Evans G.A., Athanasiou M., Schultz R., Roe B.A., Chen F., Pan H., Ramser J., Lehrach H., Reinhardt R., McCombie W.R., de la Bastide M., Dedhia N., Blocker H., Hornischer K., Nordsiek G., Agarwala R., Aravind L., Bailey J.A., Bateman A., Batzoglou S., Birney E., Bork P., Brown D.G., Burge C.B., Cerutti L., Chen H.C., Church D., Clamp M., Copley R.R., Doerks T., Eddy S.R., Eichler E.E., Furey T.S., Galagan J., Gilbert J.G., Harmon C., Hayashizaki Y., Haussler D., Hermjakob H., Hokamp K., Jang W., Johnson L.S., Jones T.A., Kasif S., Kaspryzk A., Kennedy S., Kent W.J., Kitts P., Koonin E.V., Korf I., Kulp D., Lancet D., Lowe T.M., McLysaght A., Mikkelsen T., Moran J.V., Mulder N., Pollara V.J., Ponting C.P., Schuler G., Schultz J., Slater G., Smit A.F., Stupka E., Szustakowski J., Thierry-Mieg D., Thierry-Mieg J., Wagner L., Wallis J., Wheeler R., Williams A., Wolf Y.I., Wolfe K.H., Yang S.P., Yeh R.F., Collins F., Guyer M.S., Peterson J., Felsenfeld A., Wetterstrand K.A., Patrinos A., Morgan M.J., Szustakowki J., de Jong P., Catanese J.J., Osoegawa K., Shizuya H., Choi S., Chen Y.J. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
79. Langhorne J., Ndungu F.M., Sponaas A.M., Marsh K. Immunity to malaria: more questions than answers. Nat. Immunol. 2008, 9:725-732.
80. Lasonder E., Ishihama Y., Andersen J.S., Vermunt A.M., Pain A., Sauerwein R.W., Eling W.M., Hall N., Waters A.P., Stunnenberg H.G., Mann M. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature 2002, 419:537-542.
81. Lasonder E., Janse C.J., van Gemert G.J., Mair G.R., Vermunt A.M., Douradinha B.G., van Noort V., Huynen M.A., Luty A.J., Kroeze H., Khan S.M., Sauerwein R.W., Waters A.P., Mann M., Stunnenberg H.G. Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity. PLoS Pathog. 2008, 4:e1000195.
82. Le Roch K.G., Zhou Y., Blair P.L., Grainger M., Moch J.K., Haynes J.D., De La Vega P., Holder A.A., Batalov S., Carucci D.J., Winzeler E.A. Discovery of gene function by expression profiling of the malaria parasite life cycle. Science 2003, 301:1503-1508.
83. Le Roch K.G., Johnson J.R., Florens L., Zhou Y., Santrosyan A., Grainger M., Yan S.F., Williamson K.C., Holder A.A., Carucci D.J., Yates J.R., Winzeler E.A. Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle. Genome Res. 2004, 14:2308-2318.
84. Li B., Jiang L., Song Q., Yang J., Chen Z., Guo Z., Zhou D., Du Z., Song Y., Wang J., Wang H., Yu S., Yang R. Protein microarray for profiling antibody responses to Yersinia pestis live vaccine. Infect. Immun. 2005, 73:3734-3739.
85. Liew K.J., Hu G., Bozdech Z., Peter P.R. Defining species specific genome differences in malaria parasites. BMC Genomics 2010, 11:128.
86. Llinas M., DeRisi J.L. Pernicious plans revealed: Plasmodium falciparum genome wide expression analysis. Curr. Opin. Microbiol. 2004, 7:382-387.
87. Llinas M., Bozdech Z., Wong E.D., Adai A.T., DeRisi J.L. Comparative whole genome transcriptome analysis of three Plasmodium falciparum strains. Nucleic Acids Res 2006, 34:1166-1173.
88. Lopez J.E., Beare P.A., Heinzen R.A., Norimine J., Lahmers K.K., Palmer G.H., Brown W.C. High-throughput identification of T-lymphocyte antigens from Anaplasma marginale expressed using in vitro transcription and translation. J. Immunol. Meth. 2008, 332:129-141.
89. Mackinnon M.J., Li J., Mok S., Kortok M.M., Marsh K., Preiser P.R., Bozdech Z. Comparative transcriptional and genomic analysis of Plasmodium falciparum field isolates. PLoS Pathog. 2009, 5:e1000644.
90. Mair G.R., Braks J.A., Garver L.S., Wiegant J.C., Hall N., Dirks R.W., Khan S.M., Dimopoulos G., Janse C.J., Waters A.P. Regulation of sexual development of Plasmodium by translational repression. Science 2006, 313:667-669.
91. Malkin E., Long C.A., Stowers A.W., Zou L., Singh S., MacDonald N.J., Narum D.L., Miles A.P., Orcutt A.C., Muratova O., Moretz S.E., Zhou H., Diouf A., Fay M., Tierney E., Leese P., Mahanty S., Miller L.H., Saul A., Martin L.B. Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malaria. PLoS Clin. Trials 2007, 2:e12.
92. Marsh K., Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol. 2006, 28:51-60.
93. Marti M., Good R.T., Rug M., Knuepfer E., Cowman A.F. Targeting malaria virulence and remodeling proteins to the host erythrocyte. Science 2004, 306:1930-1933.
94. McCarthy J.S., Good M.F. Whole parasite blood stage malaria vaccines: a convergence of evidence. Hum. Vaccine 2010, 6:114-123.
95. McConkey S.J., Reece W.H., Moorthy V.S., Webster D., Dunachie S., Butcher G., Vuola J.M., Blanchard T.J., Gothard P., Watkins K., Hannan C.M., Everaere S., Brown K., Kester K.E., Cummings J., Williams J., Heppner D.G., Pathan A., Flanagan K., Arulanantham N., Roberts M.T., Roy M., Smith G.L., Schneider J., Peto T., Sinden R.E., Gilbert S.C., Hill A.V. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat. Med. 2003, 9:729-735.
96. McGregor A., Carrington S.P. Treatment of East African P. falciparum malaria with West African human gamma-globulin. Trans. R. Soc. Trop. Med. Hyg. 1963, 57-3:170-175.
97. Mehlin C., Boni E., Buckner F.S., Engel L., Feist T., Gelb M.H., Haji L., Kim D., Liu C., Mueller N., Myler P.J., Reddy J.T., Sampson J.N., Subramanian E., Van Voorhis W.C., Worthey E., Zucker F., Hol W.G. Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes. Mol. Biochem. Parasitol. 2006, 148:144-160.
98. Mikolajczak S.A., Aly A.S., Dumpit R.F., Vaughan A.M., Kappe S.H. An efficient strategy for gene targeting and phenotypic assessment in the Plasmodium yoelii rodent malaria model. Mol. Biochem. Parasitol. 2008, 158:213-216.
99. Mikolajczak S.A., Silva-Rivera H., Peng X., Tarun A.S., Camargo N., Jacobs-Lorena V., Daly T.M., Bergman L.W., de la Vega P., Williams J., Aly A.S., Kappe S.H. Distinct malaria parasite sporozoites reveal transcriptional changes that cause differential tissue infection competence in the mosquito vector and mammalian host. Mol. Cell Biol. 2008, 28:6196-6207.
100. Mochon A.B., Ye J., Kayala M.A., Wingard J.R., Clancy C.J., Nguyen M.H., Felgner P., Baldi P., Liu H. Serological profiling of a Candida albicans protein microarray reveals permanent host-pathogen interplay and stage-specific responses during candidemia. PLoS Pathog. 2010, 6:e1000827.
101. Molina D.M., Pal S., Kayala M.A., Teng A., Kim P.J., Baldi P., Felgner P.L., Liang X., de la Maza L.M. Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarrays. Vaccine 2010, 28:3014-3024.
102. Moorthy V.S., Imoukhuede E.B., Milligan P., Bojang K., Keating S., Kaye P., Pinder M., Gilbert S.C., Walraven G., Greenwood B.M., Hill A.S. A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults. PLoS Med. 2004, 1:e33.
103. Moriel D.G., Scarselli M., Serino L., Mora M., Rappuoli R., Masignani V. Genome-based vaccine development: a short cut for the future. Adv. Exp. Med. Biol. 2009, 655:81-89.
104. Mueller A.K., Camargo N., Kaiser K., Andorfer C., Frevert U., Matuschewski K., Kappe S.H. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc. Natl. Acad. Sci. USA 2005, 102:3022-3027.
105. Mueller A.K., Labaied M., Kappe S.H., Matuschewski K. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 2005, 433:164-167.
106. Nussenzweig V., Nussenzweig R.S. Rationale for the development of an engineered sporozoite malaria vaccine. Adv. Immunol. 1989, 45:283-334.
107. Ogutu B.R., Apollo O.J., McKinney D., Okoth W., Siangla J., Dubovsky F., Tucker K., Waitumbi J.N., Diggs C., Wittes J., Malkin E., Leach A., Soisson L.A., Milman J.B., Otieno L., Holland C.A., Polhemus M., Remich S.A., Ockenhouse C.F., Cohen J., Ballou W.R., Martin S.K., Angov E., Stewart V.A., Lyon J.A., Heppner D.G., Withers M.R. Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PLoS ONE 2009, 4:e4708.
108. Oliner J.D., Kinzler K.W., Vogelstein B. In vivo cloning of PCR products in E. coli. Nucleic Acids Res. 1993, 21:5192-5197.
109. Oliveira G.A., Kumar K.A., Calvo-Calle J.M., Othoro C., Altszuler D., Nussenzweig V., Nardin E.H. Class II-restricted protective immunity induced by malaria sporozoites. Infect. Immun. 2008, 76:1200-1206.
110. Orjih A.U., Cochrane A.H., Nussenzweig R.S. Comparative studies on the immunogenicity of infective and attenuated sporozoites of Plasmodium berghei. Trans. R. Soc. Trop. Med. Hyg. 1982, 76:57-61.
111. Oseroff C., Peters B., Pasquetto V., Moutaftsi M., Sidney J., Panchanathan V., Tscharke D.C., Maillere B., Grey H., Sette A. Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve. J. Immunol. 2008, 180:7193-7202.
112. Osier F.H., Fegan G., Polley S.D., Murungi L., Verra F., Tetteh K.K., Lowe B., Mwangi T., Bull P.C., Thomas A.W., Cavanagh D.R., McBride J.S., Lanar D.E., Mackinnon M.J., Conway D.J., Marsh K. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite
113. Ozawa K., Headlam M.J., Schaeffer P.M., Henderson B.R., Dixon N.E., Otting G. Optimization of an Escherichia coli system for cell-free synthesis of selectively N-labelled proteins for rapid analysis by NMR spectroscopy. Eur. J. Biochem. 2004, 271:4084-4093.
114. Pain A., Bohme U., Berry A.E., Mungall K., Finn R.D., Jackson A.P., Mourier T., Mistry J., Pasini E.M., Aslett M.A., Balasubrammaniam S., Borgwardt K., Brooks K., Carret C., Carver T.J., Cherevach I., Chillingworth T., Clark T.G., Galinski M.R., Hall N., Harper D., Harris D., Hauser H., Ivens A., Janssen C.S., Keane T., Larke N., Lapp S., Marti M., Moule S., Meyer I.M., Ormond D., Peters N., Sanders M., Sanders S., Sargeant T.J., Simmonds M., Smith F., Squares R., Thurston S., Tivey A.R., Walker D., White B., Zuiderwijk E., Churcher C., Quail M.A., Cowman A.F., Turner C.M., Rajandream M.A., Kocken C.H., Thomas A.W., Newbold C.I., Barrell B.G., Berriman M. The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature 2008, 455:799-803.
115. Price R.N., Tjitra E., Guerra C.A., Yeung S., White N.J., Anstey N.M. Vivax malaria: neglected and not benign. Am. J. Trop. Med. Hyg. 2007, 77:79-87.
116. Price R.N., Douglas N.M., Anstey N.M. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr. Opin. Infect. Dis. 2009, 22:430-435.
117. Putrianti E.D., Silvie O., Kordes M., Borrmann S., Matuschewski K. Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. J. Infect. Dis. 2009, 199:899-903.
118. Regis D.P., Dobano C., Quinones-Olson P., Liang X., Graber N.L., Stefaniak M.E., Campo J.J., Carucci D.J., Roth D.A., He H., Felgner P.L., Doolan D.L. Transcriptionally active PCR for antigen identification and vaccine development: in vitro genome-wide screening and in vivo immunogenicity. Mol. Biochem. Parasitol. 2008, 158:32-45.
119. Richie T.L. Malaria vaccines for travelers. Travel. Med. Infect. Dis. 2004, 2:193-210.
120. Rinaudo C.D., Telford J.L., Rappuoli R., Seib K.L. Vaccinology in the genome era. J. Clin. Invest. 2009, 119:2515-2525.
121. Roestenberg M., McCall M., Hopman J., Wiersma J., Luty A.J., van Gemert G.J., van de Vegte-Bolmer M., van Schaijk B., Teelen K., Arens T., Spaarman L., de Mast Q., Roeffen W., Snounou G., Renia L., van der Ven A., Hermsen C.C., Sauerwein R. Protection against a malaria challenge by sporozoite inoculation. N. Engl. J. Med. 2009, 361:468-477.
122. Rosinski-Chupin I., Chertemps T., Boisson B., Perrot S., Bischoff E., Briolay J., Couble P., Menard R., Brey P., Baldacci P. Serial analysis of gene expression in Plasmodium berghei salivary gland sporozoites. BMC Genomics 2007, 8:466.
123. Sabchareon A., Burnouf T., Ouattara D., Attanath P., Bouharoun-Tayoun H., Chantavanich P., Foucault C., Chongsuphajaisiddhi T., Druilhe P. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am. J. Trop. Med. Hyg. 1991, 45:297-308.
124. Sacci J.B., Ribeiro J.M., Huang F., Alam U., Russell J.A., Blair P.L., Witney A., Carucci D.J., Azad A.F., Aguiar J.C. Transcriptional analysis of in vivo Plasmodium yoelii liver stage gene expression. Mol. Biochem. Parasitol. 2005, 142:177-183.
125. Sachs J., Malaney P. The economic and social burden of malaria. Nature 2002, 415:680-685.
126. Sagara I., Dicko A., Ellis R.D., Fay M.P., Diawara S.I., Assadou M.H., Sissoko M.S., Kone M., Diallo A.I., Saye R., Guindo M.A., Kante O., Niambele M.B., Miura K., Mullen G.E., Pierce M., Martin L.B., Dolo A., Diallo D.A., Doumbo O.K., Miller L.H., Saul A. A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali. Vaccine 2009, 27:3090-3098.
127. Sargeant T.J., Marti M., Caler E., Carlton J.M., Simpson K., Speed T.P., Cowman A.F. Lineage-specific expansion of proteins exported to erythrocytes in malaria parasites. Genome Biol. 2006, 7:R12.
128. Sattabongkot J., Yimamnuaychoke N., Leelaudomlipi S., Rasameesoraj M., Jenwithisuk R., Coleman R.E., Udomsangpetch R., Cui L., Brewer T.G. Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am. J. Trop. Med. Hyg. 2006, 74:708-715.
129. Schofield L., Mueller I. Clinical immunity to malaria. Curr. Mol. Med. 2006, 6:205-221.
130. Seib K.L., Dougan G., Rappuoli R. The key role of genomics in modern vaccine and drug design for emerging infectious diseases. PLoS Genet. 2009, 5:e1000612.
131. Sercarz E.E., Lehmann P.V., Ametani A., Benichou G., Miller A., Moudgil K. Dominance and crypticity of T cell antigenic determinants. Ann. Rev. Immunol. 1993, 11:729-766.
132. Sette A., Sidney J. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr. Opin. Immunol. 1998, 10:478-482.
133. Sette A., Fleri W., Peters B., Sathiamurthy M., Bui H.H., Wilson S. A roadmap for the immunomics of category A-C pathogens. Immunity 2005, 22:155-161.
134. Sette A., Peters B. Immune epitope mapping in the post-genomic era: lessons for vaccine development. Curr. Opin. Immunol. 2007, 19:106-110.
135. Sharma J., Zhong Y., Dong F., Piper J.M., Wang G., Zhong G. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect. Immun. 2006, 74:1490-1499.
136. Siau A., Silvie O., Franetich J.F., Yalaoui S., Marinach C., Hannoun L., van Gemert G.J., Luty A.J., Bischoff E., David P.H., Snounou G., Vaquero C., Froissard P., Mazier D. Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection. PLoS Pathog 2008, 4:e1000121.
137. Sidney J., Peters B., Frahm N., Brander C., Sette A. HLA class I supertypes: a revised and updated classification. BMC Immunol. 2008, 9:1.
138. Silvie O., Semblat J.P., Franetich J.F., Hannoun L., Eling W., Mazier D. Effects of irradiation on Plasmodium falciparum sporozoite hepatic development: implications for the design of pre-erythrocytic malaria vaccines. Parasite Immunol. 2002, 24:221-223.
139. Singh A.P., Buscaglia C.A., Wang Q., Levay A., Nussenzweig D.R., Walker J.R., Winzeler E.A., Fujii H., Fontoura B.M., Nussenzweig V. Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. Cell 2007, 131:492-504.
140. Snow R.W., Marsh K. The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv Parasitol 2002, 52:235-264.
141. Southwood S., Sidney J., Kondo A., del Guercio M.F., Appella E., Hoffman S., Kubo R.T., Chesnut R.W., Grey H.M., Sette A. Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. 1998, 160:3363-3373.
142. Spring M.D., Cummings J.F., Ockenhouse C.F., Dutta S., Reidler R., Angov E., Bergmann-Leitner E., Stewart V.A., Bittner S., Juompan L., Kortepeter M.G., Nielsen R., Krzych U., Tierney E., Ware L.A., Dowler M., Hermsen C.C., Sauerwein R.W., de Vlas S.J., Ofori-Anyinam O., Lanar D.E., Williams J.L., Kester K.E., Tucker K., Shi M., Malkin E., Long C., Diggs C.L., Soisson L., Dubois M.C., Ballou W.R., Cohen J., Heppner D.G. Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. PLoS ONE 2009, 4:e5254.
143. Sundaresh S., Doolan D.L., Hirst S., Mu Y., Unal B., Davies D.H., Felgner P.L., Baldi P. Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques. Bioinformatics 2006, 22:1760-1766.
144. Sundaresh S., Randall A., Unal B., Petersen J.M., Belisle J.T., Hartley M.G., Duffield M., Titball R.W., Davies D.H., Felgner P.L., Baldi P. From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis. Bioinformatics 2007, 23:i508-518.
145. Tarun A.S., Baer K., Dumpit R.F., Gray S., Lejarcegui N., Frevert U., Kappe S.H. Quantitative isolation and in vivo imaging of malaria parasite liver stages. Int. J. Parasitol. 2006, 36:1283-1293.
146. Tarun A.S., Peng X., Dumpit R.F., Ogata Y., Silva-Rivera H., Camargo N., Daly T.M., Bergman L.W., Kappe S.H. A combined transcriptome and proteome survey of malaria parasite liver stages. Proc. Natl. Acad. Sci. USA 2008, 105:305-310.
147. Teklehaimanot A., McCord G.C., Sachs J.D. Scaling up malaria control in Africa: an economic and epidemiological assessment. Am. J. Trop. Med. Hyg. 2007, 77:138-144.
148. Tjitra E., Anstey N.M., Sugiarto P., Warikar N., Kenangalem E., Karyana M., Lampah D.A., Price R.N. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008, 5:e128.
149. Tsuboi T., Takeo S., Arumugam T.U., Otsuki H., Torii M. The wheat germ cell-free protein synthesis system: a key tool for novel malaria vaccine candidate discovery. Acta Trop. 2010, 114:171-176.
150. Tsuboi T., Takeo S., Iriko H., Jin L., Tsuchimochi M., Matsuda S., Han E.T., Otsuki H., Kaneko O., Sattabongkot J., Udomsangpetch R., Sawasaki T., Torii M., Endo Y. Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect. Immun. 2008, 76:1702-1708.
151. van der Most R.G., Sette A., Oseroff C., Alexander J., Murali-Krishna K., Lau L.L., Southwood S., Sidney J., Chesnut R.W., Matloubian M., Ahmed R. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 1996, 157:5543-5554.
152. van Ooij C., Tamez P., Bhattacharjee S., Hiller N.L., Harrison T., Liolios K., Kooij T., Ramesar J., Balu B., Adams J., Waters A.P., Janse C.J., Haldar K. The malaria secretome: from algorithms to essential function in blood stage infection. PLoS Pathog. 2008, 4:e1000084.
153. Vaughan A.M., Wang R., Kappe S.H. Genetically engineered, attenuated whole-cell vaccine approaches for malaria. Hum. Vaccine 2010, 6:107-113.
154. Vedadi M., Lew J., Artz J., Amani M., Zhao Y., Dong A., Wasney G.A., Gao M., Hills T., Brokx S., Qiu W., Sharma S., Diassiti A., Alam Z., Melone M., Mulichak A., Wernimont A., Bray J., Loppnau P., Plotnikova O., Newberry K., Sundararajan E., Houston S., Walker J., Tempel W., Bochkarev A., Kozieradzki I., Edwards A., Arrowsmith C., Roos D., Kain K., Hui R. Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms. Mol. Biochem. Parasitol. 2007, 151:100-110.
155. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R., Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K., Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D., McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M., Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C., Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B., Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J., Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E., Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X. The sequence of the human genome. Science 2001, 291:1304-1351.
156. Vigil A., Davies D.H., Felgner P.L. Defining the humoral immune response to infectious agents using high-density protein microarrays. Future Microbiol. 2010, 5:241-251.
157. Vigil, A., Ortega, R., Nakajima-Sasaki, R., Pablo, J., Molina, D.M., Chao, C.C., Chen, H.W., Ching, W.M., Felgner, P.L., 2010b. Genome-wide profiling of humoral immune response to Coxiella burnetii infection by protein microarray. Proteomics.
158. Villard V., Agak G.W., Frank G., Jafarshad A., Servis C., Nebie I., Sirima S.B., Felger I., Arevalo-Herrera M., Herrera S., Heitz F., Backer V., Druilhe P., Kajava A.V., Corradin G. Rapid identification of malaria vaccine candidates based on alpha-helical coiled coil protein motif. PLoS ONE 2007, 2:e645.
159. Volkman S.K., Sabeti P.C., DeCaprio D., Neafsey D.E., Schaffner S.F., Milner D.A., Daily J.P., Sarr O., Ndiaye D., Ndir O., Mboup S., Duraisingh M.T., Lukens A., Derr A., Stange-Thomann N., Waggoner S., Onofrio R., Ziaugra L., Mauceli E., Gnerre S., Jaffe D.B., Zainoun J., Wiegand R.C., Birren B.W., Hartl D.L., Galagan J.E., Lander E.S., Wirth D.F. A genome-wide map of diversity in Plasmodium falciparum. Nat Genet 2007, 39:113-119.
160. von Itzstein M., Plebanski M., Cooke B.M., Coppel R.L. Hot, sweet and sticky: the glycobiology of Plasmodium falciparum. Trends Parasitol. 2008, 24:210-218.
161. Vyas J.M., Van der Veen A.G., Ploegh H.L. The known unknowns of antigen processing and presentation. Nat. Rev. Immunol. 2008, 8:607-618.
162. Wang Q., Brown S., Roos D.S., Nussenzweig V., Bhanot P. Transcriptome of axenic liver stages of Plasmodium yoelii. Mol. Biochem. Parasitol. 2004, 137:161-168.
163. Weber J.L. Molecular biology of malaria parasites. Exp. Parasitol. 1988, 66:143-170.
164. + T cells in immunity to malaria sporozoites. J. Immunol. 1993, 151:2690-2698.
165. Westenberger S.J., McClean C.M., Chattopadhyay R., Dharia N.V., Carlton J.M., Barnwell J.W., Collins W.E., Hoffman S.L., Zhou Y., Vinetz J.M., Winzeler E.A. A systems-based analysis of Plasmodium vivax lifecycle transcription from human to mosquito. PLoS Negl Trop Dis 2010, 4:e653.
166. Wu C.C., MacCoss M.J., Mardones G., Finnigan C., Mogelsvang S., Yates J.R., Howell K.E. Organellar proteomics reveals Golgi arginine dimethylation. Mol. Biol. Cell 2004, 15:2907-2919.
167. Yadava A., Ockenhouse C.F. Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems. Infect. Immun. 2003, 71:4961-4969.
168. Yang Z.R., Lertmemongkolchai G., Tan G., Felgner P.L., Titball R. A genetic programming approach for Burkholderia pseudomallei diagnostic pattern discovery. Bioinformatics 2009, 25:2256-2262.
169. Yewdell J.W., Haeryfar S.M. Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design. Annu. Rev. Immunol. 2005, 23:651-682.
170. Yewdell J.W. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity 2006, 25:533-543.
171. Yewdell J.W. Plumbing the sources of endogenous MHC class I peptide ligands. Curr. Opin. Immunol. 2007, 19:79-86.
172. Zhou Y., Young J.A., Santrosyan A., Chen K., Yan S.F., Winzeler E.A. In silico gene function prediction using ontology-based pattern identification. Bioinformatics 2005, 21:1237-1245.
173. Zhou Y., Ramachandran V., Kumar K.A., Westenberger S., Refour P., Zhou B., Li F., Young J.A., Chen K., Plouffe D., Henson K., Nussenzweig V., Carlton J., Vinetz J.M., Duraisingh M.T., Winzeler E.A. Evidence-based annotation of the malaria parasite's genome using comparative expression profiling. PLoS ONE 2008, 3:e1570.
174. Zinkernagel R.M., Doherty P.C. H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D. J. Exp. Med. 1975, 141:1427-1436.